The study of control technique of interspecies signal transfer
The study of control technique of interspecies signal transfer
批准号:
08559002
负责人:
TANAKA Tomoo
金额:
$10.69万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
为了检测种间信号传递的物质,我们使用了抗人脑和寄生原虫克氏锥虫(Trypanosoma cruzi(Wood))的单克隆抗体。J.N.et等,Nature,1982)。我们对人体组织和克氏锥虫cDNA文库进行了筛选,获得了几个新基因。其中,北方印迹法筛选出在人脑、心肌和克氏锥虫中表达的新基因Bradeion,这些基因最初是用单克隆抗体检测到的。对该基因及其蛋白的结构和功能进行了初步研究:1. Bradeion在成年人脑中表达为两种类型(称为a和beta)。其氨基酸序列具有生长激素和细胞因子受体的基序。它也被认为是一个孤儿受体,具有跨膜区和ATP/GTP结合位点. Bradejon在北方印迹中仅在成年人脑和心脏(占脑的10%)上有信号,在其他组织和胚胎期均无信号.只有布拉德洪的β型 ...更多信息 在小鼠脑中表达(与人Bradeion β具有94%的同一性)。该基因位于小鼠染色体VH上,由3个外显子和2个内含子组成,覆盖约100个外显子。17 kb.4. Bradeion α定位于线粒体,Bradeion β定位于核周细胞质.转染Bradeion的人培养癌细胞发生凋亡. Bradeion基因在人大肠癌和恶性黑色素瘤细胞中也有表达。这种表达也在人结肠癌和恶性黑色素瘤患者的样品中观察到。反义核酶转染大肠癌细胞后,其生长速度明显减慢,转化率明显降低,对阿尔茨海默病、亨廷顿病等神经退行性疾病的分子病理学进行了研究,以控制神经细胞的衰老和防止神经细胞的死亡。基于这项研究的新医学和医疗机械也正在开发中。此外,还进行了使用动物模型(如秀丽隐杆线虫或小鼠)发现有关物质的试验及其在人体中的应用。然而,由于脑系统的组织和细胞具有种属和个体差异性,使研究受到限制。因此,需要建立使用人培养细胞的方法。Bradeion是从人与其他生物体的共同进化或生物体对环境的适应的角度出发,通过研究获得的一种与人类神经元的存活(死亡)有关的新物质,即Bradeion。例如,因此,我们的研究证实了新的细胞年龄控制因子Bradeion的发现及其功能分析。根据这些发现,我们开始了以下研究,将Bradeion作为一个新的全球性行业的种子:1。一种新的人脑β受体Bradeion作为有用的生理激活剂的功能分析.分析了神经元收缩形成非常复杂的高级结构和发生程序性细胞死亡的机制.开发用于控制神经死亡、早期癌症诊断和癌症基因治疗的技术和医疗机械。少
英文摘要
To detect the substance of interspecies signal transfer, we used the monoclonal antibody specific to human brain and parasitic protozoa, Trypanosoma cruzi (Wood. J.N.et al., Nature, 1982). We screened human tissues and T.cruzi cDNA library, and obtained several novel genes. Among them, Northern blot selected novel gene Bradeion expressing in human brain, cardiac muscle and T.cruzi, which were originally detected by the monoclonal antibody. We got the following structural and functional characterization about this gene and its protein :1. Bradeion was expressed as two types (called as a and beta) in adult human brain. The amino acid alignment of it has the motif of growth hormone and cytokine receptor. It was also considered as an orphan receptor with transmembrane region and ATP/GTP binding site.2. The signal of Bradejon in Northern blot was shown only on adult human brain and heart (10% of brain), and no signal in any other tissues and embryonic stage.3. Only beta-type of Bradejon was … More expressed in mouse brain (94% identity to human Bradeion beta). This gene is located in mouse chromosome VH and exists as 3 exons and 2 introns covering ca. 17 kb.4. Bradeion alpha was located in mitochondria and Bradeion beta in perinuclear cytoplasm.5. Apoptosis occurs in human cultured cancer cell in which Bradeion was transfected.6. Bradeion gene was also expressed in human cultured cancer cells of colorectal cancer and malignant melanoma. This expression was also observed in the samples of human colorecial cancer and malignant melanoma patients.7. The remarkable decrease of growth and the transformation in cultured colorectal cancer cell were observed when antisense ribozyme was transfected.The molecular pathology of neural degenerative disease like Alzheimer disease and Huntington disease has been studied to control the age and prevention of death of neural cell. New medicine and medical machinery based on this study are also developing now. Furthermore, the trial finding the related substance using animal models like C.elegans or mouse and its application to human have been performed. However, the study is limited by the species and individual differences, which the tissue and the cell of the cerebral system have. The establishment of the methodology to use human culture cell is therefore needed. Bradeion is quite a novel substance concerning to flue survival (death) of human neuron gained by approach from the point of view considering co-evolution of human and other organisms or adaptation of organism to environment, i. e., "parasitism".Consequently, our study demonstrated the discovery of new control factor of cell age, Bradeion and its functional analysis. According to these findings, we started the following studies to apply Bradeion as the seed of a new and global industry now :1. Analysis of function of a new human brain orphan-receptor, Bradeion as useful physiological activator.2. Analysis of the mechanism how neurons contract very complex and high-grade structure and the programmed cell death of neuron happens.3. Development of technology and medical machinery for control of neural death, diagnosis of early cancer and gene therapy of cancer. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tanaka T: "Differential Diagnosis of Trpanosoma cruzi and T.rangeli Infection by PCR of Cysteine Proteinase Genes" J Jpn Assoc Inf Dis. 71・9. 903-909 (1997)
Tanaka T:“通过半胱氨酸蛋白酶基因的PCR对克氏锥虫和兰格利锥虫感染进行鉴别诊断”J Jpn Assoc Inf Dis. 71・909。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka M.,et al: "Schistosoma mansoni Genome Project Network" Parasitology Today. (in press). (1996)
Tanaka M.等人:“曼氏血吸虫基因组计划网络”今日寄生虫学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka M: "The Triplet Repcat(Alanine;GCT)in Ribosomal Protein L14 of Immortalized Human Endothelial Cell Line(t-HUEA)." Biochemical and Biophysical Research Communications. (in press). (1998)
Tanaka M:“永生化人内皮细胞系 (t-HUEA) 核糖体蛋白 L14 中的三联体 Repcat(丙氨酸;GCT)。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka,M.,et al: "Proceedings of Schistozoma genome Project/96" Mem.Inst.Oswald Cruz.(in press). (1996)
Tanaka,M.,et al:“裂殖虫基因组计划/96”Mem.Inst.Oswald Cruz.(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka M: "The Triplet Repeat (Alanine ; GCT) in Ribosomal Protein L14 of Immortalized Human Endothelial Cell Line (t-HUE4)." Biochemical and Biophysical Research Communications. 243・2. 531-537 (1998)
田中 M:“永生化人内皮细胞系 (t-HUE4) 核糖体蛋白 L14 中的三联体重复序列(丙氨酸;GCT)”,《生物化学和生物物理研究通讯》243·2。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Study of the prevention and complementary treatment of advanced cancer: Examination of presymptomatic diagnosis and reactivation of cancer suppression mechanism
-
批准号:16K09258
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2016
-
负责人:TANAKA Tomoo
-
依托单位:
The study of the development of anti-cancer drug which targets human septin 4 (Bradeion) GTPase
-
批准号:22501052
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:TANAKA Tomoo
-
依托单位:
Development of cancer therapeutic technology by functional measurement and control of cell division.
-
批准号:18590540
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:TANAKA Tomoo
-
依托单位:
Development of monitoring system of colorectal cancer
-
批准号:15590499
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2003
-
负责人:TANAKA Tomoo
-
依托单位:
海外基金